BRIEF-Bio-Rad Q4 Sales USD 693.2 Million Vs. IBES Estimate USD 688.8 Million

Reuters
Feb 13
BRIEF-Bio-Rad Q4 Sales USD 693.2 Million Vs. IBES Estimate USD 688.8 Million

Feb 12 (Reuters) - Bio-Rad Q4 gross margin 49.8%.

  • Q4 net income USD 720 million
  • Q4 EPS USD 26.65
  • outlook FY adjusted revenue growth 0.5-1.5%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10